Altimmune Inc (NAS:ALT)
$ 3.015 -0.050 (-1.64%) Market Cap: 586.34 Mil Enterprise Value: 287.73 Mil PE Ratio: 0 PB Ratio: 1.38 GF Score: 30/100

Altimmune Inc RECLAIM Phase 2 Trial in AUD Topline Results Conference Call Transcript

Jul 28, 2026 / 12:00 PM GMT
Release Date Price: $2.99 (+1.01%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ALT.OQ - Altimmune Inc
Altimmune Inc RECLAIM Phase 2 Trial in AUD Topline Results Conference Call
Jul 28, 2026 / 12:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning, ladies and gentlemen, and welcome to the Altimmune RECLAIM Phase 2 Trial in AUD Top-Line Results Conference Call.

At this time, all participants are in a listen-only mode.

After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you'll need to press *11 on your telephone. You will then hear an automated message advising your hand is raised.

To withdraw your question, please press *11 again.

As a reminder, this call is being recorded.

I'll now introduce your host for today's conference call, Louis Sine, Vice President of Investor Relations. Louis, you may begin.

--------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot